In order to investigate the role of APRIL and its receptors in NSCLC, we firstly evaluated the expression levels of APRIL, BCMA and TACI by using immunohistochemistry in tissue sections from human NSCLC samples tissue micro array (Figure 1A). This evidence concerns the gene TNFRSF13B and non-small cell lung carcinoma.